Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant
Authors:
Open Access
- 2 November 2021
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 78 (23) , 7899-7914
Abstract
The lipophilic polycyclic aromatic hydrocarbon (PAH) phenanthrene is relatively abundant in polluted air and water and can access and accumulate in human tissue. Phenanthrene has been reported to interact with cardiac ion channels in several fish species. This study was undertaken to investigate the ability of phenanthrene to interact with hERG (human Ether-à-go-go-Related Gene) encoded Kv11.1 K+ channels, which play a central role in human ventricular repolarization. Pharmacological inhibition of hERG can be proarrhythmic. Whole-cell patch clamp recordings of hERG current (IhERG) were made from HEK293 cells expressing wild-type (WT) and mutant hERG channels. WT IhERG1a was inhibited by phenanthrene with an IC50 of 17.6 ± 1.7 µM, whilst IhERG1a/1b exhibited an IC50 of 1.8 ± 0.3 µM. WT IhERG block showed marked voltage and time dependence, indicative of dependence of inhibition on channel gating. The inhibitory effect of phenanthrene was markedly impaired by the attenuated inactivation N588K mutation. Remarkably, mutations of S6 domain aromatic amino acids (Y652, F656) in the canonical drug binding site did not impair the inhibitory action of phenanthrene; the Y652A mutation augmented IhERG block. In contrast, the F557L (S5) and M651A (S6) mutations impaired the ability of phenanthrene to inhibit IhERG, as did the S624A mutation below the selectivity filter region. Computational docking using a cryo-EM derived hERG structure supported the mutagenesis data. Thus, phenanthrene acts as an inhibitor of the hERG K+ channel by directly interacting with the channel, binding to a distinct site in the channel pore domain.Keywords
All Related Versions
Funding Information
- British Heart Foundation (PG/17/77/33125, PG/17/89/33414, PG/20/10252, FS/19/44/34424, PG /19/26/34302)
This publication has 83 references indexed in Scilit:
- Metabolism of [D10]Phenanthrene to Tetraols in Smokers for Potential Lung Cancer Susceptibility Assessment: Comparison of Oral and Inhalation Routes of AdministrationThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Mechanistic Insight into Human ether-à-go-go-related Gene (hERG) K+ Channel Deactivation Gating from the Solution Structure of the EAG DomainJournal of Biological Chemistry, 2011
- Characterization of PM2.5-bound polycyclic aromatic hydrocarbons in Atlanta—Seasonal variations at urban, suburban, and rural ambient air monitoring sitesAtmospheric Environment, 2009
- Pharmacology of the short QT syndrome N588K‐hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugsBritish Journal of Pharmacology, 2008
- Physiological Properties of hERG 1a/1b Heteromeric Currents and a hERG 1b-Specific Mutation Associated With Long-QT SyndromeCirculation Research, 2008
- Mechanism of hERG K+channel blockade by the fluoroquinolone antibiotic moxifloxacinBritish Journal of Pharmacology, 2006
- Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channelJournal of Molecular and Cellular Cardiology, 2006
- Local Anesthetic Interaction with Human Ether-a-go-go –related Gene (HERG) ChannelsAnesthesiology, 2005
- Occurrence of gaseous and particulate polycyclic aromatic hydrocarbons in the urban atmosphere: study of sources and ambient temperature effect on the gas/particle concentration and distributionEnvironmental Pollution, 2005
- High affinity HERG K+ channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656Biochemical and Biophysical Research Communications, 2004